Mechanistic registry to examine whether the coronavirus disease 2019 (COVID-19) accelerates atherosclerotic plaque progression
		
	
		
			
				| Sponsor: | 
				National Cancer Institute | 
			
			
			
				| Enrolling: | 
									Male and Female Patients | 
							
						
							
					| Clinic Visits: | 
					2 | 
				
			
			
                            
                    | IRB Number: | 
                    AAAT9812 | 
                
            
					
			
				| Contact:  | 
				Michelle Castillo: 732-277-7644 / mc5067@cumc.columbia.edu | 
			
		
	
		We are seeking patients that have had a pre-COVID heart CT scan (Coronary Computed Tomography Angiography) that was performed at Columbia University Irving Medical Center/NewYork-Presbyterian Hospital before March of 2020. For this study, half of patients will be required to have had COVID-19 symptoms (e.g., fever, cough, shortness of breath) and would have tested positive for COVID-19 (by an FDA-approved test). The other half will not have had a prior diagnosis of COVID-19. If you enroll in the study, you will be given a CT, asked to provide a blood sample as well as answer the study questionnaires, and get an ECG done.  The total duration of the tests is 3 hours. It can be done in 1 or 2 study visits, whichever works best for your schedule. You will be compensated $100 after all tests are completed.
	
	
	   	
		Investigator
		
		Andrew Einstein, MD
		
							
			   
	
		
		
		
			
				
					| Have you had a heart CT (coronary computed tomography angiography) before March 2020 at Columbia? | 
					Yes | 
					No | 
				
				
									
						| Have you have COVID-19? | 
						Yes | 
						No | 
					
								
									
						| Did you visit an urgent care, emergency department or a COVID clinic for care? | 
						Yes | 
						No | 
					
				
									
						| Were you admitted to the hospital with COVID? | 
						Yes | 
						No | 
					
				
									
						| Did you get a lipid (cholesterol) test done? | 
						Yes | 
						No |